VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

PROSCA/BLADDR 2022 | Role of neoadjuvant chemotherapy in patients undergoing bladder-sparing treatments

Aristotelis Bamias, MD, University of Athens, Athens, Greece, explores the role of neoadjuvant chemotherapy in patients undergoing bladder-sparing treatments, highlighting that it is currently not part of routine clinical practice, however its use is associated with delays in the initiation of radiotherapy. This interview took place at the Global Congress on Prostate and Bladder Cancer (PROSCA/BLADDR 2022) in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter